Insights

Pharmacy provision of clinical services is important to patient access and outcomes. As patients access more services from pharmacies, the data interoperability of those pharmacies becomes more important to the healthcare system at-large. Pharmacy teams’ ability to provide optimal care and meaningfully contribute to the value-based care transformation depends on their ability to access and … Read more

Today, Leavitt Partners, an HMA Company released a report outlining steps federal and state policymakers, technology and electronic health record (EHR) companies, health plans, pharmacies, and other healthcare providers can take to strengthen pharmacy data interoperability. As patients access more services from pharmacies, the data interoperability of those pharmacies becomes increasingly important to patients and … Read more

Washington, D.C., March 22, 2023 — The CARIN Alliance, a multi-sector collaborative of healthcare and other stakeholders working to advance the consumer-directed exchange of health information released a report today that lays the foundation for how individuals can voluntarily digital identity proof themselves once and use that same digital credential with multiple data holders of … Read more

Digital health has experienced a rapid transformation in the last two years since the beginning of the COVID-19 pandemic, dramatically shifting how care is delivered to patients. To better understand the rapid changes occurring in the industry and capitalize on future market movements, Leavitt Partners has created a digital health taxonomy and standardized definitions, along with robust market segmentations and … Read more

As efforts continued at the beginning of 2022 to implement the No Surprises Act aimed at preventing surprise medical bills that patients are often unable to pay, the Kaiser Family Foundation published a report that estimates nearly one in 10 adults have medical debt, and that Americans’ total medical debt could be as high as $195 billion. … Read more

Cell and gene therapies (CGTs) are some of the most promising and exciting medical advancements taking place today. Some existing CGTs treat previously untreatable rare diseases, and there are hundreds of CGTs in clinical development to treat various types of cancer, hemophilia, sickle cell and other blood disorders, Alzheimer’s disease, and numerous rare conditions. The … Read more

As the health care industry moves toward population-based models of care, providers are seeking partnerships to help manage the continuum of services. In order to find success in these partnerships, there is a need to identify the characteristics of providers that will yield a high degree of value for the ACO, their patients, and community. This series … Read more